European Commission grants marketing authorization to Valneva’s COVID-19 vaccine
The logo of Franco-Austrian biotechnology company Valneva is seen outside its headquarters in Vienna, Austria, December 16, 2021. REUTERS/Lisi Niesner Join now for FREE unlimited access to Reuters.com Register June 24 (Reuters) – French drugmaker Valneva’s COVID-19 vaccine (VLS.PA) has received marketing authorization from the European Commission (EC) for useRead More →